IDEXX Laboratories, Inc. (IDXX) posted first-quarter 2024 earnings per share (EPS) of $2.81, up 10.2% year over year. The figure surpassed the Zacks Consensus Estimate by 4.9%.In the first quarter of 2024, comparable constant-currency EPS of $2.71 improved 8.8% year over year.Revenues in DetailFirst-quarter revenues increased 7.1% year over year (7% organically) to $964.1 million. However, the metric missed the Zacks Consensus Estimate by 0.1%.The year-over-year upside was primarily driven by the 7% reporte ...